Since 2013, ASH has helped hematologists continue their critical blood disease research amidst severe funding reductions for the National Institutes of Health (NIH). Each year, approximately 20-30 one-year awards of $150,000 are granted to ASH members who applied for an NIH R01 grant or equivalent but were denied funding due to budget cutbacks. The ASH Bridge Grant program is intended to help sustain recipients' research and contribute to their retention in hematology investigation.
Deadlines: May 1, 2024
Eligibility Requirements
o be eligible for the ASH Bridge Grant Award all applicants must:
- Have submitted a hematology-related R01 or equivalent application to NIH in the past 18 months that was scored but not funded.
- Please note: This can include a first time submission.
- ASH uses the NIH definition of R01 equivalence: “R01-equivalent awards include R01, R23, R29, and R37 activity codes and, beginning in fiscal year 2008, DP2 awards to first-time NIH investigators. Not all of these activities are in use by NIH every year.”
- The 18 month timeline is linked specifically to the date your R01 was reviewed by the NIH study section.
- Be an ASH member or have a pending application for membership at the time of application. ASH membership details can be found in the membership section of the website.
- If you have a pending application and are awarded a Bridge Grant Award, your award will be conditional based upon membership approval
- Hold a faculty position in an academic institution or the equivalent position in a non-profit research organization. Employees of independent research institutions are eligible to apply if they have a faculty type appointment and the institution is allowed to independently apply for and receive NIH funding.